Putnam Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $367K | Hold |
4,536
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q3 | $340K | Sell |
4,536
-3,531
| -44% | -$272K | ﹤0.01% | 1033 |
|
|
2023
Q2 | $622K | Hold |
8,067
| – | – | ﹤0.01% | 893 |
|
|
2023
Q1 | $669K | Buy |
8,067
+142
| +2% | +$11.8K | ﹤0.01% | 903 |
|
|
2022
Q4 | $680K | Sell |
7,925
-684
| -8% | -$54.2K | ﹤0.01% | 887 |
|
|
2022
Q3 | $531K | Sell |
8,609
-157
| -2% | -$9.9K | ﹤0.01% | 926 |
|
|
2022
Q2 | $542K | Sell |
8,766
-317
| -3% | -$19.6K | ﹤0.01% | 927 |
|
|
2022
Q1 | $540K | Sell |
9,083
-207
| -2% | -$13.2K | ﹤0.01% | 978 |
|
|
2021
Q4 | $675K | Sell |
9,290
-64,332
| -87% | -$4.43M | ﹤0.01% | 905 |
|
|
2021
Q3 | $5.14M | Sell |
73,622
-176,354
| -71% | -$12.4M | 0.01% | 509 |
|
|
2021
Q2 | $17.2M | Buy |
249,976
+240,675
| +2,588% | +$16.1M | 0.03% | 277 |
|
|
2021
Q1 | $601K | Sell |
9,301
-257
| -3% | -$16.6K | ﹤0.01% | 700 |
|
|
2020
Q4 | $557K | Sell |
9,558
-260,311
| -96% | -$15.7M | ﹤0.01% | 728 |
|
|
2020
Q3 | $17.1M | Sell |
269,869
-254,619
| -49% | -$17.7M | 0.03% | 261 |
|
|
2020
Q2 | $40.4M | Sell |
524,488
-506,903
| -49% | -$38.8M | 0.09% | 157 |
|
|
2020
Q1 | $77.1M | Buy |
1,031,391
+53,911
| +6% | +$3.73M | 0.2% | 116 |
|
|
2019
Q4 | $63.5M | Sell |
977,480
-2,236,811
| -70% | -$146M | 0.13% | 157 |
|
|
2019
Q3 | $204M | Buy |
3,214,291
+16,120
| +0.5% | +$1.05M | 0.45% | 65 |
|
|
2019
Q2 | $216M | Buy |
3,198,171
+2,626
| +0.1% | +$173K | 0.48% | 57 |
|
|
2019
Q1 | $208M | Buy |
3,195,545
+34,149
| +1% | +$2.27M | 0.48% | 59 |
|
|
2018
Q4 | $198M | Sell |
3,161,396
-388,961
| -11% | -$27.2M | 0.52% | 55 |
|
|
2018
Q3 | $274M | Sell |
3,550,357
-196,000
| -5% | -$14.8M | 0.59% | 43 |
|
|
2018
Q2 | $265M | Buy |
3,746,357
+218,743
| +6% | +$15.4M | 0.6% | 42 |
|
|
2018
Q1 | $266M | Sell |
3,527,614
-110,081
| -3% | -$8.75M | 0.62% | 35 |
|
|
2017
Q4 | $261M | Sell |
3,637,695
-845,105
| -19% | -$64.2M | 0.58% | 39 |
|
|
2017
Q3 | $363M | Buy |
4,482,800
+2,609,214
| +139% | +$200M | 0.84% | 24 |
|
|
2017
Q2 | $133M | Sell |
1,873,586
-319,368
| -15% | -$21.3M | 0.31% | 94 |
|
|
2017
Q1 | $149M | Sell |
2,192,954
-688,190
| -24% | -$48.4M | 0.35% | 76 |
|
|
2016
Q4 | $206M | Sell |
2,881,144
-83,905
| -3% | -$6.24M | 0.5% | 49 |
|
|
2016
Q3 | $235M | Sell |
2,965,049
-296,744
| -9% | -$24.1M | 0.56% | 44 |
|
|
2016
Q2 | $272M | Sell |
3,261,793
-1,367,049
| -30% | -$121M | 0.66% | 33 |
|
|
2016
Q1 | $425M | Sell |
4,628,842
-190,183
| -4% | -$17.2M | 1.01% | 15 |
|
|
2015
Q4 | $488M | Buy |
4,819,025
+78,741
| +2% | +$8.19M | 1.1% | 15 |
|
|
2015
Q3 | $465M | Buy |
4,740,284
+240,512
| +5% | +$26.7M | 1.04% | 13 |
|
|
2015
Q2 | $527M | Buy |
4,499,772
+39,185
| +0.9% | +$4.28M | 1.06% | 13 |
|
|
2015
Q1 | $438M | Sell |
4,460,587
-570,795
| -11% | -$58M | 0.87% | 18 |
|
|
2014
Q4 | $474M | Sell |
5,031,382
-373,881
| -7% | -$38.7M | 0.97% | 13 |
|
|
2014
Q3 | $575M | Sell |
5,405,263
-518,169
| -9% | -$50.7M | 1.22% | 10 |
|
|
2014
Q2 | $491M | Buy |
5,923,432
+385,093
| +7% | +$30M | 1.06% | 13 |
|
|
2014
Q1 | $392M | Buy |
5,538,339
+387,808
| +8% | +$30.4M | 0.89% | 16 |
|
|
2013
Q4 | $387M | Buy |
5,150,531
+1,144,369
| +29% | +$79.7M | 0.93% | 11 |
|
|
2013
Q3 | $252M | Buy |
4,006,162
+291,707
| +8% | +$17.4M | 0.67% | 31 |
|
|
2013
Q2 | $190M | Buy |
+3,714,455
| New | +$194M | 0.55% | 40 |
|
Other funds holding GILD
Putnam Investments's GILD Position: Q4 2023 in Review
Putnam Investments held its Gilead Sciences (GILD) position steady in Q4 2023 at 4,536 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.
Putnam Investments first reported a position in GILD in Q2 2013 and has held it in 43 quarters since. The position peaked at $575M in Q3 2014. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Putnam Investments held 4,536 shares of Gilead Sciences worth $367K as of Q4 2023.
- Putnam Investments left its Gilead Sciences share count unchanged in Q4 2023.
- Gilead Sciences made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1046 holding.
- Putnam Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's Gilead Sciences position peaked at $575M in Q3 2014.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.